CPHRF (Cipher Pharmaceuticals) Interest Expense: $-0.75 Mil (TTM As of Mar. 2026)

What is Cipher Pharmaceuticals Interest Expense?

Cipher Pharmaceuticals CPHRF 96 Interest Expense is $-0.75 Mil as of Mar. 2026. GuruFocus rates CPHRF with a GF Score™ of 96/100 and a GF Value™ of $11.77 (Fairly Valued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cipher Pharmaceuticals's interest expense for the three months ended in Mar. 2026 was $ -0.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.75 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cipher Pharmaceuticals's Operating Income for the three months ended in Mar. 2026 was $ 5.60 Mil. Cipher Pharmaceuticals's Interest Expense for the three months ended in Mar. 2026 was $ -0.05 Mil. Cipher Pharmaceuticals's Interest Coverage for the quarter that ended in Mar. 2026 was 109.71. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cipher Pharmaceuticals (OTCPK:CPHRF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cipher Pharmaceuticals's Interest Expense for the three months ended in Mar. 2026 was $-0.05 Mil. Its Operating Income for the three months ended in Mar. 2026 was $5.60 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $0.17 Mil.

Cipher Pharmaceuticals's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	5.595	/	-0.051
	=	109.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Cipher Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for Cipher Pharmaceuticals's Interest Expense can be seen below:

Cipher Pharmaceuticals Interest Expense Chart

Cipher Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.09

0.00

-1.17

Cipher Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.47	-0.35	-0.24	-0.11	-0.05

96GF Score

Cipher Pharmaceuticals Inc CPHRF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cipher Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.75 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.75 Mil mean?

Cipher Pharmaceuticals (CPHRF) has a Interest Expense of $-0.75 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cipher Pharmaceuticals and its competitors.

Is Cipher Pharmaceuticals' Interest Expense too high?

Cipher Pharmaceuticals' current Interest Expense is $-0.75 Mil. Overall, Cipher Pharmaceuticals has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Cipher Pharmaceuticals' Interest Expense compare to ZTS and UTHR?

Cipher Pharmaceuticals' Interest Expense of $-0.75 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Drug Manufacturers company?

A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cipher Pharmaceuticals and its competitors. Cipher Pharmaceuticals's current Interest Expense is $-0.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cipher Pharmaceuticals stock overvalued right now?

Based on GuruFocus' analysis, Cipher Pharmaceuticals (CPHRF) is currently considered Fairly Valued. The stock's GF Value™ is $11.77, compared to a current price of $11.77 — trading 0% below its estimated fair value. The current Interest Expense is $-0.75 Mil. Cipher Pharmaceuticals' overall GF Score™ is 96/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Cipher Pharmaceuticals (CPHRF), the current Interest Expense is $-0.75 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cipher Pharmaceuticals (CPHRF) Overvalued in 2026?

Based on GuruFocus' analysis, Cipher Pharmaceuticals stock appears to be undervalued. The current stock price of $11.77 is trading 0% below its estimated GF Value™ of $11.77. GuruFocus considers Cipher Pharmaceuticals to be Fairly Valued.

Key valuation signals for CPHRF:

Interest Expense: $-0.75 Mil
GF Value™: $11.77 vs. price of $11.77 (0% below fair value)
GF Score™: 96/100 with 5 warning signs

No single metric tells the full story. See the CPHRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cipher Pharmaceuticals Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XCNQ:CL TSX:TSND TSX:WEED NEOE:VRNO TSX:XLY TSX:ACB TSX:OGI TSX:CRDL TSX:LOVE TSXV:RX XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges PHE:Germany CPH:Canada

Address 5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9

Website https://www.cipherpharma.com

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.

96GF Score

Get the complete analysis for CPHRF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.77

Price

$11.77

GF Value

View CPHRF Analysis

See Interest Expense data for all stocks →